Restore Protections for Dialysis Patients Act
- Sponsor
- Rep. Kelly, Mike [R-PA-16]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Mar 18, 2025
Bottom line
The "Restore Protections for Dialysis Patients Act" seeks to reinforce existing Medicare Secondary Payer rules to prevent private health plans from discriminating against ESRD patients or limiting dialysis benefits, thereby ensuring private plans remain primary payers for these services.
What it actually does
This bill amends the Medicare Secondary Payer Act (MSPA) to explicitly prohibit private health plans from discriminating against individuals with End-Stage Renal Disease (ESRD) or disproportionately limiting benefits for dialysis services. It clarifies that plans cannot differentiate in benefits or apply limitations, including network composition, that disparately affect ESRD patients, while affirming that plans are not required to include specific dialysis providers in their networks. The bill aims to prevent private plans from shifting the cost burden of ESRD care to Medicare.
Proponents argue
Supporters argue that this bill is crucial for protecting vulnerable ESRD patients from discriminatory practices by private health insurers who may try to steer them towards Medicare. They contend that current practices, such as limiting dialysis networks or offering less favorable terms for dialysis, undermine the intent of the MSPA and place an undue financial burden on the Medicare program and, ultimately, taxpayers. Proponents believe this clarification will ensure equitable access to care for ESRD patients and uphold the principle that private plans should be primary payers when available.
Opponents contend
Opponents, likely from the health insurance industry, might argue that the bill could restrict their ability to manage costs and design efficient provider networks. They may contend that current MSPA interpretations already provide sufficient protections and that this bill could lead to increased premiums or reduced flexibility in plan design, potentially impacting a broader range of enrollees. Some might also argue that plans should have the flexibility to manage their networks to ensure quality and cost-effectiveness, and that this bill could be overly prescriptive.
The bill is very short and straightforward, making it highly accessible for a reader to understand its core provisions and intent within a few minutes.
Section 3, amending Section 1862(b)(1)(C) of the Social Security Act
Clarification of Non-Discrimination and Benefit Limitations for ESRD Patients
This provision amends the Medicare Secondary Payer Act to explicitly state that private group health plans cannot differentiate in benefits between individuals with End-Stage Renal Disease (ESRD) and other covered individuals. It also prohibits plans from applying any benefit limitation, including those related to provider network composition, that would disproportionately affect ESRD patients. However, it clarifies that plans are not required to include specific renal dialysis providers in their networks. The Secretary is directed to enforce these rules consistent with existing regulations (42 CFR part 411).
Supporters argue
Supporters argue this provision is essential to close loopholes that allow private insurers to subtly or overtly discriminate against ESRD patients, thereby forcing them onto Medicare prematurely. They contend it ensures that private plans fulfill their primary payer obligations, protecting patients from financial hardship and preserving Medicare's resources for its intended purpose.
Critics contend
Critics, particularly from the insurance industry, might argue that the provision, especially the "disparately affect" language, could be overly broad and limit their ability to manage costs and design efficient, high-quality provider networks. They may contend it could lead to increased administrative burdens and potentially higher premiums if plans are restricted in how they can contract with dialysis providers or structure benefits.
Tradeoffs
The provision balances the goal of protecting vulnerable ESRD patients from discrimination and ensuring private plans bear their share of costs, against concerns from insurers about potential restrictions on their ability to manage networks and control costs. It seeks to prevent "patient steering" while preserving some flexibility for plans in network composition.
Directs the Secretary to enforce the amended non-discrimination provisions consistent with the nonconformance determination requirements set forth in part 411 of title 42, Code of Federal Regulations.
Section 3, final new sentence
Why it matters:This is standard legislative practice to refer to existing regulatory frameworks for enforcement. It ensures continuity and leverages established administrative processes rather than creating new ones from scratch.
Case for: Supporters would argue that referencing 42 CFR part 411 provides a clear, established framework for enforcement, ensuring consistency and predictability for both insurers and patients. It avoids the need to develop new regulations, streamlining implementation.
Case against: Critics might argue that relying on existing regulations, which may not have been specifically designed for the nuances of the new statutory language, could lead to interpretive challenges or unintended consequences. It might also limit the flexibility of future enforcement actions if the regulations are not fully aligned with the bill's intent.
Estimated impact: This provision clarifies the administrative and legal pathway for enforcing the bill's non-discrimination clauses, influencing how disputes are resolved and how compliance is monitored.